Small Stocks, Big Money

CEO Frank Basa joins RedChip to break down Nord Precious Metals' (TSXV: NTH | OTCQB: NPMMF) two-track strategy in one of Canada's richest historic silver districts. Nord controls the Castle Mine project in Ontario's historic cobalt-silver camp, where initial results came in at over 8,000 grams per tonne silver in narrow, one-to-two-foot-wide veins. The company's two-track approach...

Ken Glaser, Senior Vice President of Sales at Alliance Entertainment (Nasdaq: AENT), breaks down how the company's independent retail channel is generating early market intelligence — and why that advantage matters for the broader $1B+ platform. Alliance Entertainment is one of the largest distributors and omnichannel fulfillment partners in the global entertainment and collectibles market, su...

Paul Mann, CEO of ASP Isotopes (Nasdaq: ASPI), joins us to break down the company's shift from isotope developer to commercial-scale critical materials supplier. ASP Isotopes uses its proprietary Aerodynamic Separation Process and Quantum Enrichment technology to produce isotopes and critical gases for semiconductors, nuclear medicine, and clean energy. The world is facing real shortages in th...

Co-CEO Bob Brilon joins RedChip to discuss Bimergen Energy's (NYSE American: BESS) strategy for building, financing, and operating utility-scale and distributed battery energy storage systems across the fastest-growing power markets in the United States. Bimergen develops battery farms — tractor-trailer-sized battery systems deployed across 10 to 30 acres — with a typical project capacity of 1...

CEO Lavell Juan Malloy II joins RedChip to discuss Brag House (Nasdaq: TBH), a media-tech platform building at the intersection of Gen Z fandom, blockchain infrastructure, and global athlete IP.Brag House is built on the belief that culture is capital. With its shareholder-approved merger with House of Doge — the official corporate arm of the Dogecoin Foundation — the company is evolving into a fu...

In our investor-focused interview, James Foster, CEO of Virax Biolabs Group Ltd. (Nasdaq: VRAX), breaks down how the company is developing a potential first-in-category immune function diagnostic targeting post-acute infection syndromes (PAIS) — a large, underserved category affecting an estimated 21 million people in the U.S. with no widely adopted objective diagnostic test. Virax's lead prod...

In our investor-focused interview, Jeremy Schwartz, Global CIO of WisdomTree (NYSE: WT), breaks down how the firm grew from 20 funds to a $165B global asset manager delivering 50% annual earnings growth — and why he believes WT trades at a significant discount to its true growth profile. Jeremy covers WisdomTree's framework for identifying durable mega-trends, the $5B European defense ETF laun...

In our exclusive interview, John Passalacqua, CEO & Director of First Phosphate ($FRSPF | CSE: PHOS), discusses the seismic $94 million all-cash acquisition by Avenir Minerals (Agnico Mines subsidiary) and explains what it signals for the LFP battery supply chain and for First Phosphate. Key topics from the interview include:• Agnico Eagle's $94M all-cash acquisition of Fox River Resources...

Anixa Biosciences (Nasdaq: ANIX) is advancing a clinical-stage oncology pipeline focused on cancer vaccines and CAR-T therapy, led by its breast cancer vaccine program developed with Cleveland Clinic and supported by U.S. Department of Defense funding. In our exclusive interview, Dr. Amit Kumar, Chairman & CEO of Anixa Biosciences, discusses the company’s breast cancer vaccine targeting alpha-...

In our exclusive interview, Brandon Robinson, Co-Founder, CEO, and Director of New Horizon Aircraft (Nasdaq: HOVR) breaks down why Horizon is taking a different path in advanced air mobility and why investors are starting to pay attention. Horizon’s Cavorite X7 is designed to combine vertical takeoff capability with the speed, range, and economics of a conventional aircraft. The company is targeti...

In our exclusive interview, John Passalacqua, CEO & Director of First Phosphate, explains why First Phosphate ($FRSPF | CSE: PHOS) is positioning itself as a critical North American supplier to the fast-growing LFP battery market. Key topics from the interview include:• A $16.7 million non-dilutive contribution from the Government of Canada, helping advance feasibility work and key process val...

This week's episode of Small Stocks Big Money features exclusive interviews with senior executives from Enlivex Therapeutics Ltd. (NASDAQ: ENLV) & Off The Hook Inc. (NYSE American: OTH)Explore the latest insights and updates in the world of small-cap stocks. Visit RedChip.com to learn more.

In our exclusive interview, Jay Hatfield (Founder, CEO, and Portfolio Manager at InfraCap) outlines a disciplined approach to small-cap investing built around profitability, valuation, and income generation and discusses the opportunity set for small caps as macro conditions evolve. Jay breaks down the portfolio construction behind InfraCap Small Cap Income Fund (NYSE: SCAP), designed to target 7%...

Watch our replay of Enlivex’s FY25 Financial Results Webcast to hear management discuss the company’s outlook, financial performance, and its differentiated dual strategy combining quality longevity therapeutics with a prediction markets treasury model. Key FY2025 Highlights:• Net income of $1.23 billion• Diluted EPS of $25.48• Total treasury and treasury-related derivative assets of $2.31 billion...

Enlivex (Nasdaq: ENLV) CEO Oren Hershkovitz breaks down the company’s two-pillar strategy designed to build shareholder value through both biotech execution and balance sheet strategy. Pillar 1: Clinical Development (AllocetraTM)Enlivex is advancing its immunotherapy platform with a focus on knee osteoarthritis, a large and growing market with limited effective treatment options. In the interview,...

Off The Hook (NYSE American: OTH) CEO Brian John joins us for an exclusive interview to break down what makes OTH different from a traditional boat dealer and why management believes the company is entering a major growth phase. In our conversation, Brian explains how Off The Hook’s AI-powered platform helps price and move used boats with speed and accuracy, positioning the company as a high-veloc...

What makes Comprehensive Healthcare Systems (OTCQB: CMHSF | TSXV: CHS) a story investors should be watching right now? In our exclusive interview, Chris Cosgrove, President & CEO of Comprehensive Healthcare Systems, breaks down how the company is building a scalable healthcare SaaS platform designed to automate complex benefits administration for unions, self-insured employers, third-party adm...

​  @themetalscompany  (Nasdaq: TMC) is a developer of lower-impact critical metals from seafloor polymetallic nodules, on a dual mission: (1) supply metals for energy, defense, manufacturing and infrastructure with net positive impacts compared to conventional production routes and (2) trace, recover and recycle the metals we supply to help create a metal commons that can be used in perpetuity. Th...

BioVie (Nasdaq: BIVI) President and CEO Cuong Do joins us for an exclusive investor interview discussing BioVie’s late-clinical-stage pipeline and upcoming milestones across neurodegeneration and liver disease. In our conversation, Cuong outlines why BioVie is targeting TNFα-mediated inflammation and insulin resistance with bezisterim (formerly NE3107), plus the company’s second program, BIV201, f...

Lithium iron phosphate (LFP) batteries now power the majority of global battery production, but supply chains remain heavily concentrated in Asia. In our exclusive interview, First Phosphate (OTCQX: FRSPF | CSE: PHOS | FSE: KD0) CEO John Passalacqua explains how the company is working to onshore a full North American LFP supply chain, starting with high-purity igneous phosphate in Quebec and progr...

In our investor-focused interview, Mark White, CEO of Nexalin Technology (Nasdaq: NXL), breaks down how the company is building a non-invasive neurostimulation platform aimed at major unmet needs across brain health, including depression, insomnia, PTSD/TBI, and Alzheimer’s/dementia. Nexalin’s mission is to lead what it calls the “brain health movement” with treatment designed to be safe, effectiv...

Darren Wang, Founder, Chairman, and CEO of OBOOK Holdings (Nasdaq: OWLS), joins us to discuss how OwlTing is building a compliance-first stablecoin and fiat payment infrastructure for global commerce, as well as what investors should watch in 2026.In our interview, Darren explains why stablecoins are moving beyond speculation into real-world settlement, how OwlPay supports enterprise-scale integra...

NioCorp (Nasdaq: NB) CEO Mark Smith joins us to break down a milestone year for the Elk Creek Critical Minerals Project in Nebraska and what could be next for U.S. onshoring of niobium, scandium, and magnetic rare earths. NioCorp is positioning Elk Creek as a construction-ready, fully permitted U.S. critical minerals project with long-duration potential and exposure to national security and next-g...

Join  @RedChip  for an investor Q&A webinar with ASP Isotopes (Nasdaq: ASPI) Executive Chairman and CEO Paul Mann, covering ASPI’s transition into commercial isotope production and its strategy at the intersection of clean energy, advanced semiconductors, and nuclear medicine. In our session, Paul addresses timelines for revenue-generating isotope shipments, updates on key facilities, capital...

In our in-depth interview, Scott Monteith, CEO of Avalon Advanced Materials (OTCQB: AVLNF), breaks down why Avalon is emerging as one of North America’s most strategically positioned critical minerals companies.🔗 Avalon Advanced Materials is a client of RedChip. To learn more about AVLNF and to read our full disclosure, visit: AVLNFinfo.com.#AVLNF #LithiumStocks #RareEarthStocks #CriticalMinerals...